These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4275497)

  • 1. [Urinary excretion of mucopolysaccharides in patients with collagen diseases (author's transl)].
    Kreysel HW; Köhler A
    Dermatologica; 1974; 148(1):19-27. PubMed ID: 4275497
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of urinary acid mucopolysaccharides in dermatological collagen diseases].
    Rossi A
    G Ital Dermatol Minerva Dermatol; 1969 Dec; 44(12):641-5. PubMed ID: 4243640
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hydroxyproline excretion in urine in chronic connective tissue disease].
    Emmrich R
    Z Gesamte Inn Med; 1970 Dec; 25(23):1062-5. PubMed ID: 4397769
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the secretion of 2,5 dihydroxyphenylpyruvic acid in collagen diseases].
    Hladíková D; Sobĕslavský C; Susta A; Havelka S
    Fysiatr Revmatol Vestn; 1968 Jul; 46(4):201-9. PubMed ID: 5691511
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of urinary hydroxyproline excretion].
    Kreysel HW; Köhler N
    Med Welt; 1973 Oct; 24(43):1654-8. PubMed ID: 4764061
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quantitative isolation of acid mucopolysaccharides from urine in progressive scleroderma (author's transl)].
    Kreysel HW; Kraus H; Stuhlsatz HW; Greiling E; Nissen HP; Kimmig J
    Arch Dermatol Res (1975); 1977 Jul; 259(1):11-9. PubMed ID: 143247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dermatologic aspects of collagen disease (author's transl)].
    Quiñones PA
    An Esp Pediatr; 1981 Jul; 15(1):63-8. PubMed ID: 7316292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigations on mucopolysaccharides in blood serum of some collagenoses].
    Balabanov K; Samsonova S
    Dermatol Wochenschr; 1965 Jul; 151(30):876-80. PubMed ID: 4221102
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary excretion of acid mucopolysaccharides by patients with lupus erythematosus.
    DI FERRANTE N; ROBBINS WC; RICH C
    J Lab Clin Med; 1957 Dec; 50(6):897-900. PubMed ID: 13481460
    [No Abstract]   [Full Text] [Related]  

  • 10. [Morphology, biochemistry and function of proteoglycans in the skin].
    Kreysel HW; Kimmig
    Hautarzt; 1975 Mar; 26(3):111-7. PubMed ID: 123888
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of collagen diseases--a questionnaire survey in Japan (author's transl)].
    Nobunaga M; Shiokawa Y
    Ryumachi; 1980 Jun; 20(3):140-50. PubMed ID: 7414429
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the modification of serum and urinary mucopolysaccharides of patients with scleroderma using gestagen therapy].
    Holzmann H; Korting GW; Morsches B
    Arch Klin Exp Dermatol; 1968; 231(2):156-60. PubMed ID: 4233426
    [No Abstract]   [Full Text] [Related]  

  • 13. [Metabolism of glycosaminoglycane, collagen, and kidney function in dermatomyositis].
    Kreysel HW; Kimmig J
    Hautarzt; 1974 Jul; 25(7):342-7. PubMed ID: 4277876
    [No Abstract]   [Full Text] [Related]  

  • 14. An approach to experimental scleroderma, using urinary glycosaminoglycans from patients with systemic scleroderma.
    Ishikawa H; Suzuki S; Horiuchi R; Sato H
    Acta Derm Venereol; 1975; 55(2):97-107. PubMed ID: 48324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of prolylhydroxyproline in rheumatic diseases.
    Bienenstock HKIBRICK AC
    Ann Rheum Dis; 1969 Jan; 28(1):28-30. PubMed ID: 5305862
    [No Abstract]   [Full Text] [Related]  

  • 16. Tyrosine metabolism in connective tissue disease. P-hydroxyphenylpyruvic acid excretion.
    McCann DS; Mitchell JG; Keech MK; Boyle AJ
    J Chronic Dis; 1967 Oct; 20(10):781-6. PubMed ID: 6080821
    [No Abstract]   [Full Text] [Related]  

  • 17. [Central nervous system involvement in collagen diseases (author's transl)].
    Kashiwazaki S
    Ryumachi; 1980 Jun; 20(3):187-98. PubMed ID: 6106296
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte responsiveness to urinary glycosaminoglycan in systemic scleroderma.
    Ishikawa H; Hattori A
    Dermatologica; 1979; 158(5):328-33. PubMed ID: 312217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on acid mucopolysaccharides in the urine. II. In collagen diseases].
    Kamikubo K
    Nihon Shonika Gakkai Zasshi; 1966 Apr; 70(4):302-8. PubMed ID: 4224598
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of acidic glycosaminoglycans (mucopolysaccharides) in urine by an ion exchange method. Application to "collagenoses", gargoylism, the nail-patella syndrome and Farber's disease.
    Wessler E
    Clin Chim Acta; 1967 May; 16(2):235-43. PubMed ID: 4226725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.